©2018 by RESSTORE. Proudly created with Wix.com

RESSTORE PROJECT 

A Multicentric and European Clinical Trial

RESSTORE is a translational project that will provide through a European multicentre randomised clinical study, essential information on safety and efficacy of intravenous cell therapy i.e. delivery of allogenic adipose tissue derived stem cells (ADSCs) in stroke patients.


The objective is to improve brain repair and recovery after ischemic stroke.


RESSTORE is funded by the European Commission H2020 programme.

 

NEWS

 

RESSTORE FIRST NEWSLETTER

June 2018


It is our pleasure to present here the first RESSTORE newsletter on behalf of the European consortium including France, Spain, Finland, Czech Republic and UK. This edition is focused on the experimental developments in the project (WP7 of the work programme).

Check out the project news

RESSTORE CONSORTIUM

29 Partners from 5 Countries

Project dates: 2015-2020
Coordination: Grenoble Alpes University, France
Budget: 6.3 M€

RESSTORE Consortium gathers 29 partners from 5 countries (France, Spain, Finland, Czech Republic and UK)

including clinical centers, cell therapy units and experimental laboratories.

To see the full list of partners, visit the following webpage

 

RESSTORE Consortium at the 2nd Annual Meeting in Seville on 6th & 7th November 2017

RESSTORE project has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 681044

EVENTS

 

ESO-KAROLINSKA STROKE UPDATE CONFERENCE, STOCKHOLM

11/11/2018 - 13/11/2018

CONTACT